Region: Asia
Category: Pharmaceuticals

Asia Pharmaceuticals

(4,793 reports matching your criteria)
  • Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19

    ... cancer caused due to the rampant proliferation of the cell. In 2021, as per our Report Statistics, more than 100 Million populations were diagnosed with cervical cancer. In women, cervical cancer ranks as the 4th ... Read More

  • Asia-Pacific Digestive Health Products Market Databank

    ... to 2029. Bakery & Cereals segment is expected to be the highest contributor to this market, with $650.5 Million in 2020, and is anticipated to reach $847.5 Million by 2029, registering a CAGR of 3.03%. ... Read More

  • Asia-Pacific Mussel Oil Market Databank

    ... Beauty & Cosmetics segment is expected to be the highest contributor to this market, with $14.6 Million in 2020, and is anticipated to reach $19.4 Million by 2029, registering a CAGR of 3.20%. Dietary Supplements ... Read More

  • Asia-Pacific Probiotics Dietary Supplements Market Databank

    ... to 2029. Chewables & Gummies segment is expected to be the highest contributor to this market, with $1,856.6 Million in 2020, and is anticipated to reach $2,631.3 Million by 2029, registering a CAGR of 3.99%. ... Read More

  • Asia-Pacific Protein Supplements Market Databank

    ... Animal-based segment is expected to be the highest contributor to this market, with $13,494.9 Million in 2020, and is anticipated to reach $26,105.9 Million by 2029, registering a CAGR of 7.66%. The report provides market ... Read More

  • Asia-Pacific Botanical Supplements Market Databank

    ... Offline segment is expected to be the highest contributor to this market, with $22,662.0 Million in 2020, and is anticipated to reach $38,940.1 Million by 2029, registering a CAGR of 6.24%. Online segment is anticipated ... Read More

  • Asia-Pacific Connected Drug Delivery Devices Market Databank

    ... from 2021 to 2029. Integrated devices segment is expected to be the highest contributor to this market, with $252.1 Million in 2020, and is anticipated to reach $587.2 Million by 2029, registering a CAGR of ... Read More

  • Asia-Pacific Healthcare Contract Market Databank

    ... Contract manufacturing segment is expected to be the highest contributor to this market, with $140,409.1 Million in 2020, and is anticipated to reach $239,311.5 Million by 2029, registering a CAGR of 6.14%. The report provides ... Read More

  • Asia-Pacific Amino Acids Market Databank

    ... Plant-Based segment is expected to be the highest contributor to this market, with $17,921.3 Million in 2020, and is anticipated to reach $31,167.1 Million by 2029, registering a CAGR of 6.39%. Animal Based segment is ... Read More

  • Asia-Pacific Oncology Market Databank

    ... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More

  • Asia-Pacific Orthopedic Soft Tissue Repair Market Databank

    ... from 2021 to 2029. Rotator Cuff Repair segment is expected to be the highest contributor to this market, with $2,163.3 Million in 2020, and is anticipated to reach $2,827.6 Million by 2029, registering a CAGR ... Read More

  • Asia-Pacific Ophthalmic Ultrasound Devices Market Databank

    ... to 2029. A-Scan segment is expected to be the highest contributor to this market, with $135,501.3 Million in 2020, and is anticipated to reach $261,140.9 Million by 2029, registering a CAGR of 7.61%. A-Scan and ... Read More

  • Asia-Pacific Sleep Disorder Market Databank

    ... Sleep apnea segment is expected to be the highest contributor to this market, with $5,274.6 Million in 2020, and is anticipated to reach $9,604.4 Million by 2029, registering a CAGR of 6.93%. Narcolepsy segment is ... Read More

  • Asia-Pacific Intrathecal Pumps Market Databank

    ... from 2021 to 2029. Pain segment is expected to be the highest contributor to this market, with $137.6 Million in 2020, and is anticipated to reach $377.3 Million by 2029, registering a CAGR of 11.91%. Read More

  • Asia-Pacific Customized Premixes Market Databank

    ... Vitamins segment is expected to be the highest contributor to this market, with $399.0 Million in 2020, and is anticipated to reach $719.6 Million by 2029, registering a CAGR of 6.81%. Nutraceuticals segment is anticipated ... Read More

  • Asia-Pacific Vitamin D Market Databank

    ... Dry segment is expected to be the highest contributor to this market, with $649.0 Million in 2020, and is anticipated to reach $1,292.6 Million by 2029, registering a CAGR of 8.00%. Liquid segment is anticipated ... Read More

  • Asia-Pacific Vitamin Supplements Market Databank

    ... Multivitamin segment is expected to be the highest contributor to this market, with $17,279.2 Million in 2020, and is anticipated to reach $32,094.6 Million by 2029, registering a CAGR of 7.17%. Vitamin E segment is ... Read More

  • Asia-Pacific Gummy Market Databank

    ... is expected to be the highest contributor to this market, with $13,410.7 Million in 2020, and is anticipated to reach $24,383.7 Million by 2029, registering a CAGR of 6.91%. The report provides market intelligence on ... Read More

  • Asia-Pacific Ophthalmic Photocoagulator Market Databank

    ... Hospitals segment is expected to be the highest contributor to this market, with $64.9 Million in 2020, and is anticipated to reach $108.4 Million by 2029, registering a CAGR of 5.91%. Ambulatory Surgery Centers segment ... Read More

  • Asia-Pacific Onychomycosis Treatment Market Databank

    ... 2021 to 2029. Drug treatment segment is expected to be the highest contributor to this market, with $2,435.6 Million in 2020, and is anticipated to reach $6,460.7 Million by 2029, registering a CAGR of 11.51%. Read More

  • Asia-Pacific Minor Cannabinoids Market Databank

    ... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More

  • Asia-Pacific Clinical Trial Supplies Market Databank

    ... to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, with $971.6 Million in 2020, and is anticipated to reach $1,851.1 Million by 2029, registering a CAGR of 7.47%. Medical device ... Read More

  • Asia-Pacific Uterine Manipulation Devices Market Databank

    ... to 2029. Total Laparoscopy Hysterectomy (TLH) segment is expected to be the highest contributor to this market, with $91.8 Million in 2020, and is anticipated to reach $137.7 Million by 2029, registering a CAGR of ... Read More

  • Asia-Pacific Yeast Beta-Glucan Market Databank

    ... Food & Beverages segment is expected to be the highest contributor to this market, with $72.7 Million in 2020, and is anticipated to reach $123.7 Million by 2029, registering a CAGR of 6.13%. Animal Feed ... Read More

  • Asia-Pacific Bioactive Ingredients Market Databank

    ... Functional beverages segment is expected to be the highest contributor to this market, with $876.5 Million in 2020, and is anticipated to reach $1,534.1 Million by 2029, registering a CAGR of 6.47%. Functional food segment ... Read More

Cookie Settings